Megan Blewett

Megan Blewett is a Co-Founder and President of Iris Medicine and also serves as Co-Founder and VP of Corporate Development at the same organization. In addition, Megan is a Board Member at Convergent Research and Co-Founder and Director of Business Development at Kelonia Therapeutics. Previously, Megan worked as a life sciences investor at Venrock. Educationally, Megan Blewett holds an AB/AM in Chemistry from Harvard University (2007-2011) and a Doctor of Philosophy (Ph.D.) in Chemistry from Scripps Research (2012-2016).